A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists
- 29 January 1994
- Vol. 15 (1) , 95-100
- https://doi.org/10.1016/0196-9781(94)90176-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antagonistic properties are shifted back to agonistic properties by further N‐terminal shortening of pituitary adenylate‐cyclase‐activating peptides in human neuroblastoma NB‐OK‐1 cell membranesEuropean Journal of Biochemistry, 1992
- Interaction of Calcitonin Gene-Related Peptides with Pancreatic Acinar Cells and Dispersed Gastric Smooth Muscle CellsAnnals of the New York Academy of Sciences, 1992
- Immunmodulation durch gastrointestinale NeuropeptideDeutsche Medizinische Wochenschrift (1946), 1990
- Determination of the backbone conformation of secretin by restrained molecular dynamics on the basis of interproton distance dataEuropean Journal of Biochemistry, 1988
- Solid phase synthesis of peptides containing the CH2NH peptide bond isosterePeptides, 1987
- A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29Peptides, 1986
- Synthesis of pseudo‐peptide analogues of the C‐terminal tetra‐peptide of gastrin and evaluation of their biological activity on acid secretionInternational Journal of Peptide and Protein Research, 1986
- Synthesis and biological activities of some pseudo-peptide analogs of tetragastrin: the importance of the peptide backboneJournal of Medicinal Chemistry, 1985
- Structure-activity studies on the N-terminal region of growth hormone releasing factorJournal of Medicinal Chemistry, 1985
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973